SCHEMBL5377871

SCHEMBL5377871

O=C(c1cc2ccccc2[nH]1)C(F)(F)F

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 4/20 0.65
KDM4E B2RXH2 3/20 0.62
MAPT P10636 1/20 0.62
DAO P14920 1/20 0.62
HPGD P15428 1/20 0.62
SRD5A2 P31213 1/20 0.62
HSD17B10 Q99714 1/20 0.62
IDO1 P14902 3/20 0.57
ALDH1A1 P00352 1/20 0.56
GAA P10253 1/20 0.56
MAPK1 P28482 1/20 0.56
PDGFRB P09619 2/20 0.55
PDGFRA P16234 2/20 0.55
LMNA P02545 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
TP53 P04637 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
HRH4 Q9H3N8 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29611845 0.88 FLT3 (0.62) FLT3KDM4EMAPTDAOHPGD
SCHEMBL27111566 0.86 KDM4E (0.54) FLT3KDM4EMAPTDAOHPGD
Indole-2-Carboxylic Acid SCHEMBL29781124 0.83 KDM4E (0.80) FLT3KDM4EMAPTDAOHPGD
SCHEMBL30862231 0.82 FLT3 (0.65) FLT3KDM4EMAPTDAOHPGD
SCHEMBL2730155 0.82 FLT3 (0.65) FLT3KDM4EMAPTDAOHPGD
SCHEMBL8429844 0.82 FLT3 (0.65) FLT3KDM4EMAPTDAOHPGD
Trifluoroacetic Acid SCHEMBL3638793 0.80 KDM4E (0.60) FLT3KDM4EMAPTDAOHPGD
SCHEMBL28471306 0.79 FLT3 (0.71) FLT3KDM4EMAPTDAOHPGD
SCHEMBL6976556 0.79 IDO1 (0.57) FLT3KDM4EMAPTDAOHPGD
SCHEMBL370573 0.79 FLT3 (1.00) FLT3KDM4EMAPTDAOHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250236590-A1 A METHOD FOR THE PREPARATION OF INDOLE-3-CARBOXYLIC ACID DERIVATIVES DEB INDUBHUSAN 2025-07-24 US disclosed
EP-4419503-A1 A METHOD FOR THE PREPARATION OF INDOLE-3-CARBOXYLIC ACID DERIVATIVES Council of Scientific and Industrial Research, an Indian Registered Body Incorporated under Regn. of Soc. Act (Act XXI of 1860) (IN) 2024-08-28 EP disclosed
CN-118265698-A Process for preparing indole-3-carboxylic acid derivatives 科学与工业研究会(按照印度社会团体注册法案(1860年第21号法案)设立的注册机构) 2024-06-28 CN disclosed
CN-116574048-A Bromination reaction method of remote indole C-H bond by using sunlight catalysis 陕西科技大学 2023-08-11 CN disclosed
WO-2023067628-A1 A METHOD FOR THE PREPARATION OF INDOLE-3-CARBOXYLIC ACID DERIVATIVES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) 2023-04-27 WO disclosed
WO-2021049489-A1 COMPOUND, ACID-GENERATING AGENT, COMPOSITION, CURED PRODUCT, PATTERN, AND METHODS FOR PRODUCING CURED PRODUCT AND PATTERN 株式会社ADEKA 2021-03-18 WO disclosed
US-9776979-B2 EBI2 modulators SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2017-10-03 US disclosed
CN-106946758-A A kind of synthetic method of 3 (trifluoroacetyl) indole derivativeses 丽水学院 2017-07-14 CN disclosed
CN-106946758-A A kind of synthetic method of 3 (trifluoroacetyl) indole derivativeses 丽水学院 2017-07-14 CN disclosed
US-20160214951-A1 EBI2 MODULATORS SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 2016-07-28 US disclosed
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed
EP-0922042-A1 NOVEL PIPERAZINE CONTAINING COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1999-06-16 EP disclosed
US-5834494-A SEROTONIN 5HT2B/2C RECEPTOR ANTAGONISTS; CNS NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDERS; IRRITABLE BOWEL SYNDROME SMITHKLINE BEECHAM P.L.C. (GB) 1998-11-10 US disclosed
WO-1998028292-A1 NOVEL PIPERIDINE CONTAINING COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1998-07-02 WO disclosed
WO-1998006715-A1 NOVEL PIPERAZINE CONTAINING COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1998-02-19 WO disclosed
EP-0707581-B1 INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1997-02-26 EP disclosed
EP-0707581-A1 INDOLINE DERIVATIVES AS 5HT 2C? ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-04-24 EP disclosed
EP-0697172-A1 Indoles as insecticides and acaricides AMERICAN CYANAMID COMPANY (US) 1996-02-21 EP disclosed
WO-1995001976-A1 INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160214951-A1 EBI2 MODULATORS BIRC2, HAVCR2, MAVS FLT3 2182/4885KDM4E 1496/4885MAPT 3773/4885
US-20250236590-A1 A METHOD FOR THE PREPARATION OF INDOLE-3-CARBOXYLIC ACID DERIVATIVES IDO1, INMT, IDO2 FLT3 1245/4885KDM4E 2274/4885MAPT 1841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.